Industry: Medical Devices & Consumables
Published Date: 2026-03-26
Pages: 147 Pages
Report ld: 6353118
Request Sample
Customized Report
The global Non-Hormonal IUDs market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
From a downstream perspective, Below 35 Years Old accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Non-Hormonal IUDs leading manufacturers (including CooperSurgical, Williams Medical Supplies, Laboratoire 7 MED, Bayer, Durbin, Laboratoire CCD, Prosan, OCON, SMB Corporation of India, etc.), dominate supply; the top five capture approximately % of global revenue, with CooperSurgical leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Non-Hormonal IUDs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Age, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Non-Hormonal IUDs study scope, segments the market by Type and by Age, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Age, identifies emerging use cases, and profiles leading customers by region and by Age
Chapter 6: North America: breaks down sales and revenue by Age and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Age and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Age, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Age, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Age, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Age, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Non-Hormonal IUDs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Non-Hormonal IUDs Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 T-shaped
1.2.3 U-shaped
1.3 Market Segmentation by Age
1.3.1 Global Non-Hormonal IUDs Market Size by Age, 2021 vs 2025 vs 2032
1.3.2 Below 35 Years Old
1.3.3 35 Years Old and Above
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Non-Hormonal IUDs Revenue Estimates and Forecasts (2021-2032)
2.2 Global Non-Hormonal IUDs Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Non-Hormonal IUDs Sales Estimates and Forecasts (2021-2032)
2.4 Global Non-Hormonal IUDs Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Non-Hormonal IUDs Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Non-Hormonal IUDs Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 T-shaped: Market Share by Key Manufacturers
3.5.2 U-shaped: Market Share by Key Manufacturers
3.6 Global Non-Hormonal IUDs Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Non-Hormonal IUDs Sales Performance by Type
4.1.1 Global Non-Hormonal IUDs Sales Volume by Type (2021-2032)
4.1.2 Global Non-Hormonal IUDs Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Non-Hormonal IUDs Sales by Age
5.1.1 Global Historical and Forecasted Sales by Age (2021-2032)
5.1.2 Global Sales Market Share by Age (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Non-Hormonal IUDs Revenue by Age
5.2.1 Global Historical and Forecasted Revenue by Age (2021-2032)
5.2.2 Revenue-Based Market Share by Age (2021-2032)
5.3 Global Pricing Dynamics by Age (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Age
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Non-Hormonal IUDs Sales and Revenue by Age (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Non-Hormonal IUDs Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Non-Hormonal IUDs Sales and Revenue by Age (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Non-Hormonal IUDs Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Non-Hormonal IUDs Sales and Revenue by Age (2021-2032)
8.4 Asia-Pacific Non-Hormonal IUDs Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Non-Hormonal IUDs Sales and Revenue by Age (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Non-Hormonal IUDs Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Non-Hormonal IUDs Sales and Revenue by Age (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Non-Hormonal IUDs Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 CooperSurgical
11.1.1 CooperSurgical Corporation Information
11.1.2 CooperSurgical Business Overview
11.1.3 CooperSurgical Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.1.4 CooperSurgical Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 CooperSurgical Non-Hormonal IUDs Sales by Product in 2025
11.1.6 CooperSurgical Non-Hormonal IUDs Sales by Age in 2025
11.1.7 CooperSurgical Non-Hormonal IUDs Sales by Geographic Area in 2025
11.1.8 CooperSurgical Non-Hormonal IUDs SWOT Analysis
11.1.9 CooperSurgical Recent Developments
11.2 Williams Medical Supplies
11.2.1 Williams Medical Supplies Corporation Information
11.2.2 Williams Medical Supplies Business Overview
11.2.3 Williams Medical Supplies Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.2.4 Williams Medical Supplies Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Williams Medical Supplies Non-Hormonal IUDs Sales by Product in 2025
11.2.6 Williams Medical Supplies Non-Hormonal IUDs Sales by Age in 2025
11.2.7 Williams Medical Supplies Non-Hormonal IUDs Sales by Geographic Area in 2025
11.2.8 Williams Medical Supplies Non-Hormonal IUDs SWOT Analysis
11.2.9 Williams Medical Supplies Recent Developments
11.3 Laboratoire 7 MED
11.3.1 Laboratoire 7 MED Corporation Information
11.3.2 Laboratoire 7 MED Business Overview
11.3.3 Laboratoire 7 MED Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.3.4 Laboratoire 7 MED Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Laboratoire 7 MED Non-Hormonal IUDs Sales by Product in 2025
11.3.6 Laboratoire 7 MED Non-Hormonal IUDs Sales by Age in 2025
11.3.7 Laboratoire 7 MED Non-Hormonal IUDs Sales by Geographic Area in 2025
11.3.8 Laboratoire 7 MED Non-Hormonal IUDs SWOT Analysis
11.3.9 Laboratoire 7 MED Recent Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Business Overview
11.4.3 Bayer Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.4.4 Bayer Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 Bayer Non-Hormonal IUDs Sales by Product in 2025
11.4.6 Bayer Non-Hormonal IUDs Sales by Age in 2025
11.4.7 Bayer Non-Hormonal IUDs Sales by Geographic Area in 2025
11.4.8 Bayer Non-Hormonal IUDs SWOT Analysis
11.4.9 Bayer Recent Developments
11.5 Durbin
11.5.1 Durbin Corporation Information
11.5.2 Durbin Business Overview
11.5.3 Durbin Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.5.4 Durbin Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Durbin Non-Hormonal IUDs Sales by Product in 2025
11.5.6 Durbin Non-Hormonal IUDs Sales by Age in 2025
11.5.7 Durbin Non-Hormonal IUDs Sales by Geographic Area in 2025
11.5.8 Durbin Non-Hormonal IUDs SWOT Analysis
11.5.9 Durbin Recent Developments
11.6 Laboratoire CCD
11.6.1 Laboratoire CCD Corporation Information
11.6.2 Laboratoire CCD Business Overview
11.6.3 Laboratoire CCD Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.6.4 Laboratoire CCD Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Laboratoire CCD Recent Developments
11.7 Prosan
11.7.1 Prosan Corporation Information
11.7.2 Prosan Business Overview
11.7.3 Prosan Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.7.4 Prosan Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Prosan Recent Developments
11.8 OCON
11.8.1 OCON Corporation Information
11.8.2 OCON Business Overview
11.8.3 OCON Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.8.4 OCON Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 OCON Recent Developments
11.9 SMB Corporation of India
11.9.1 SMB Corporation of India Corporation Information
11.9.2 SMB Corporation of India Business Overview
11.9.3 SMB Corporation of India Non-Hormonal IUDs Product Models, Descriptions and Specifications
11.9.4 SMB Corporation of India Non-Hormonal IUDs Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 SMB Corporation of India Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Non-Hormonal IUDs Industry Chain
12.2 Non-Hormonal IUDs Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Non-Hormonal IUDs Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Non-Hormonal IUDs Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Non-Hormonal IUDs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Non-Hormonal IUDs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Non-Hormonal IUDs market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 79
USD 4250.00
(Single User License)
The global market for Non-Hormonal IUDs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 101
USD 3950.00
(Single User License)
The global Non-Hormonal IUDs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 114
USD 2900.00
(Single User License)
The global Non-Hormonal IUDs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 145
USD 4900.00
(Single User License)
The global Non-Hormonal IUDs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 79
USD 4250.00
(Single User License)
The global market for Non-Hormonal IUDs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 91
USD 3950.00
(Single User License)
The global market for Non-Hormonal IUDs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 83
USD 2900.00
(Single User License)
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published Date: 2024-08-11
Pages: 145
USD 4900.00
(Single User License)
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published Date: 2024-08-11
Pages: 107
USD 4350.00
(Single User License)
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published Date: 2024-08-11
Pages: 87
USD 2900.00
(Single User License)
The global Non-Hormonal IUDs market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 79
The global market for Non-Hormonal IUDs was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 101
The global Non-Hormonal IUDs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 114
The global Non-Hormonal IUDs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 145
The global Non-Hormonal IUDs market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 79
The global market for Non-Hormonal IUDs was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 91
The global market for Non-Hormonal IUDs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 83
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published: 2024-08-11
Pages: 145
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published: 2024-08-11
Pages: 107
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
Published: 2024-08-11
Pages: 87
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now